ExonImpact: Prioritizing Pathogenic Alternative Splicing Events
Authors
Affiliations
Alternative splicing (AS) is a closely regulated process that allows a single gene to encode multiple protein isoforms, thereby contributing to the diversity of the proteome. Dysregulation of the splicing process has been found to be associated with many inherited diseases. However, among the pathogenic AS events, there are numerous "passenger" events whose inclusion or exclusion does not lead to significant changes with respect to protein function. In this study, we evaluate the secondary and tertiary structural features of proteins associated with disease-causing and neutral AS events, and show that several structural features are strongly associated with the pathological impact of exon inclusion. We further develop a machine-learning-based computational model, ExonImpact, for prioritizing and evaluating the functional consequences of hitherto uncharacterized AS events. We evaluated our model using several strategies including cross-validation, and data from the Gene-Tissue Expression (GTEx) and ClinVar databases. ExonImpact is freely available at http://watson.compbio.iupui.edu/ExonImpact.
Homozygous variants in WDR83OS lead to a neurodevelopmental disorder with hypercholanemia.
Barish S, Lin S, Maroofian R, Gezdirici A, Alhebby H, Trimouille A Am J Hum Genet. 2024; 111(11):2566-2581.
PMID: 39471804 PMC: 11568760. DOI: 10.1016/j.ajhg.2024.10.002.
Wang R, Helbig I, Edmondson A, Lin L, Xing Y Brief Bioinform. 2023; 24(5).
PMID: 37580177 PMC: 10516351. DOI: 10.1093/bib/bbad284.
The Impact of Pro-Inflammatory Cytokines on Alternative Splicing Patterns in Human Islets.
Wu W, Syed F, Simpson E, Lee C, Liu J, Chang G Diabetes. 2021; .
PMID: 34697029 PMC: 8763875. DOI: 10.2337/db20-0847.
Lin H, Hargreaves K, Li R, Reiter J, Wang Y, Mort M Genome Biol. 2019; 20(1):254.
PMID: 31779641 PMC: 6883696. DOI: 10.1186/s13059-019-1847-4.
When one becomes many-Alternative splicing in β-cell function and failure.
Alvelos M, Juan-Mateu J, Colli M, Turatsinze J, Eizirik D Diabetes Obes Metab. 2018; 20 Suppl 2:77-87.
PMID: 30230174 PMC: 6148369. DOI: 10.1111/dom.13388.